Related stories
Collegium Affirms FY2026 Sales Guidance of $825M-$855M
Collegium Pharmaceutical affirmed FY2026 sales guidance of $825.000M-$855.000M, versus an estimate of $835.780M.
M impact | EARNINGS | Nov 05, 2026, 12:37 PM UTC
NetScout Affirms FY2027 EPS and Sales Guidance
NetScout affirmed FY2027 adjusted EPS guidance of $2.65-$2.80 versus a $2.73 estimate and sales guidance of $885.000M-$915.000M versus a $904.739M estimate.
M impact | EARNINGS | Nov 05, 2026, 12:37 PM UTC
Cars.com Affirms FY2026 Sales Guidance at $723.239M-$737.704M
Cars.com affirmed its FY2026 sales guidance at $723.239 million to $737.704 million, versus an estimate of $728.858 million.
M impact | EARNINGS | Nov 05, 2026, 12:37 PM UTC
NetScout Affirms FY2027 GAAP EPS Guidance of $1.55-$1.70
NetScout Systems affirmed its FY2027 GAAP EPS guidance range of $1.55-$1.70; the headline also cites a $1.64 estimate.
L impact | EARNINGS | Nov 05, 2026, 12:37 PM UTC
Parker-Hannifin Expects Fiscal 2027 Adjusted EPS of $36.45–$37.25
The company’s fiscal 2027 adjusted EPS outlook is $36.45 to $37.25; FactSet estimates $35.73.
M impact | EARNINGS | Nov 05, 2026, 12:37 PM UTC
Curtiss-Wright Q3 Sales Rise 10%, Raises 2026 Guidance
Curtiss-Wright reported third-quarter 2026 sales of $952.6 million, up 10% year over year, and diluted EPS of $3.77. Adjusted diluted EPS was $3.94. It raised its 2026 sales growth
M impact | EARNINGS | Nov 05, 2026, 12:34 PM UTC